SCHEMBL1840697

SCHEMBL1840697

[CH2]CCCCCCCCC(C=O)CCCCCCCC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
ADH1B P00325 2/20 0.42
ADH1C P00326 2/20 0.42
ADH1A P07327 2/20 0.42
ADH4 P08319 2/20 0.42
ADH7 P40394 2/20 0.42
MAPT P10636 2/20 0.37
TRPA1 O75762 1/20 0.37
DDAH1 O94760 1/20 0.37
GAPDH P04406 1/20 0.37
GPR84 Q9NQS5 3/20 0.36
FDPS P14324 3/20 0.36
FFAR1 O14842 1/20 0.36
EPHX1 P07099 1/20 0.35
LMNA P02545 1/20 0.35
LCK P06239 1/20 0.35
PPARD Q03181 1/20 0.35
ZDHHC20 Q5W0Z9 1/20 0.35
ZDHHC2 Q9UIJ5 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1948724 1.00 TSHR (0.54) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL1833640 1.00 TSHR (0.54) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL1837807 1.00 TSHR (0.54) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL1952368 0.98 TSHR (0.52) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL9407677 0.96 TSHR (0.54) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL27316192 0.92 TSHR (0.48) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL23851480 0.89 TSHR (0.65) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL9395696 0.89 TSHR (0.65) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL9396374 0.89 TSHR (0.65) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL9397942 0.89 TSHR (0.65) TSHRSMN1; SMN2ADH1BADH1CADH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110144267-A1 FUNCTIONALIZED (METH)ACRYLATE MONOMER, POLYMER, COATING AGENT, AND PRODUCTION AND CROSS-LINKING METHOD EVONIK ROEHM GMBH (DE) 2011-06-16 US disclosed
US-20110136975-A1 MONOMER MIXTURE, POLYMER, COATING MEANS AND METHOD FOR PRODUCING A COATING EVONIK ROEHM GMBH (DE) 2011-06-09 US disclosed
EP-2321254-A1 FUNCTIONALIZED (METH)ACRYLATE MONOMER, POLYMER, COATING AGENT, AND PRODUCTION AND CROSS-LINKING METHOD Evonik Röhm GmbH (DE) 2011-05-18 EP disclosed
WO-2010026204-A1 FUNCTIONALIZED (METH)ACRYLATE MONOMER, POLYMER, COATING AGENT, AND PRODUCTION AND CROSS-LINKING METHOD EVONIK RÖHM GMBH (DE) 2010-03-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110144267-A1 FUNCTIONALIZED (METH)ACRYLATE MONOMER, POLYMER, COATING AGENT, AND PRODUCTION AND CROSS-LINKING METHOD DNMT1, TET1, MGMT TSHR 2023/4885SMN1; SMN2 1750/4885ADH1B 381/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.